Dabigatran Etexilate in Patients With Mechanical Heart Valves

NCT01452347 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Valve Diseases

Interventions

DRUG: warfarin 1mg
DRUG: dabigatran etexilate intermediate dose
DRUG: dabigatran etexilate low dose
DRUG: warfarin 5mg
DRUG: dabigatran etexilate high dose
DRUG: warfarin 3mg

Sponsor

Boehringer Ingelheim